These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29435051)

  • 1. Mutations in KRAS codon 12 predict poor survival in Chinese patients with metastatic colorectal cancer.
    Bai B; Shan L; Xie B; Huang X; Mao W; Wang X; Wang D; Zhu H
    Oncol Lett; 2018 Mar; 15(3):3161-3166. PubMed ID: 29435051
    [No Abstract]   [Full Text] [Related]  

  • 2. Not all mutations of
    Li W; Liu Y; Cai S; Yang C; Lin Z; Zhou L; Liu L; Cheng X; Zeng W
    Int J Clin Exp Pathol; 2019; 12(3):957-967. PubMed ID: 31933906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G12V and G12A KRAS mutations are associated with poor outcome in patients with metastatic colorectal cancer treated with bevacizumab.
    Fiala O; Buchler T; Mohelnikova-Duchonova B; Melichar B; Matejka VM; Holubec L; Kulhankova J; Bortlicek Z; Bartouskova M; Liska V; Topolcan O; Sedivcova M; Finek J
    Tumour Biol; 2016 May; 37(5):6823-30. PubMed ID: 26662311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer.
    Lavacchi D; Fancelli S; Roviello G; Castiglione F; Caliman E; Rossi G; Venturini J; Pellegrini E; Brugia M; Vannini A; Bartoli C; Cianchi F; Pillozzi S; Antonuzzo L
    Front Oncol; 2022; 12():1055019. PubMed ID: 36523988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis.
    Margonis GA; Kim Y; Spolverato G; Ejaz A; Gupta R; Cosgrove D; Anders R; Karagkounis G; Choti MA; Pawlik TM
    JAMA Surg; 2015 Aug; 150(8):722-9. PubMed ID: 26038887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KRAS Codon 12 Mutation is Associated with More Aggressive Invasiveness in Synchronous Metastatic Colorectal Cancer (mCRC): Retrospective Research.
    He K; Wang Y; Zhong Y; Pan X; Si L; Lu J
    Onco Targets Ther; 2020; 13():12601-12613. PubMed ID: 33335401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic Adenocarcinoma.
    Bournet B; Muscari F; Buscail C; Assenat E; Barthet M; Hammel P; Selves J; Guimbaud R; Cordelier P; Buscail L
    Clin Transl Gastroenterol; 2016 Mar; 7(3):e157. PubMed ID: 27010960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mutations of KRAS and BRAF in Chinese patients with colorectal carcinoma: analyses of 966 cases].
    Gao J; Sun ZW; Li YY; Shen L
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):579-83. PubMed ID: 23157823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KRAS p.G13D mutation and codon 12 mutations are not created equal in predicting clinical outcomes of cetuximab in metastatic colorectal cancer: a systematic review and meta-analysis.
    Mao C; Huang YF; Yang ZY; Zheng DY; Chen JZ; Tang JL
    Cancer; 2013 Feb; 119(4):714-21. PubMed ID: 22972628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of Ras Mutations' Prognostic Value in Metastatic Colorectal Cancer: STORIA Analysis.
    Ottaiano A; Normanno N; Facchini S; Cassata A; Nappi A; Romano C; Silvestro L; De Stefano A; Rachiglio AM; Roma C; Maiello MR; Scala S; Delrio P; Tatangelo F; Di Mauro A; Botti G; Avallone A; Nasti G
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Implication of KRAS Status after Hepatectomy for Colorectal Liver Metastases Varies According to Primary Colorectal Tumor Location.
    Sasaki K; Margonis GA; Wilson A; Kim Y; Buettner S; Andreatos N; Gani F; Amini N; Spolverato G; Pawlik TM
    Ann Surg Oncol; 2016 Oct; 23(11):3736-3743. PubMed ID: 27352204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of
    Dolatkhah R; Dastgiri S; Eftekhar Sadat AT; Farassati F; Nezamdoust M; Somi MH
    Bioimpacts; 2021; 11(1):5-14. PubMed ID: 33469503
    [No Abstract]   [Full Text] [Related]  

  • 13. The prognostic role of microsatellite instability, codon-specific KRAS, and BRAF mutations in colon cancer.
    Lin CC; Lin JK; Lin TC; Chen WS; Yang SH; Wang HS; Lan YT; Jiang JK; Yang MH; Chang SC
    J Surg Oncol; 2014 Sep; 110(4):451-7. PubMed ID: 24964758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of
    Guo T; Wu Y; Huang D; Jin Y; Sheng W; Cai S; Zhou X; Zhu X; Liu F; Xu Y
    J Cancer; 2021; 12(17):5331-5337. PubMed ID: 34335949
    [No Abstract]   [Full Text] [Related]  

  • 15. Association between specific KRAS mutations and the clinicopathological characteristics of colorectal tumors.
    Kodaz H; Hacibekiroglu I; Erdogan B; Turkmen E; Tozkir H; Albayrak D; Uzunoglu S; Cicin I
    Mol Clin Oncol; 2015 Jan; 3(1):179-184. PubMed ID: 25469291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.
    Blons H; Emile JF; Le Malicot K; Julié C; Zaanan A; Tabernero J; Mini E; Folprecht G; Van Laethem JL; Thaler J; Bridgewater J; Nørgård-Petersen L; Van Cutsem E; Lepage C; Zawadi MA; Salazar R; Laurent-Puig P; Taieb J
    Ann Oncol; 2014 Dec; 25(12):2378-2385. PubMed ID: 25294886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of KRAS Mutation on Survival Outcome of Patients With Metastatic Colorectal Cancer in Jordan.
    Alkader MS; Altaha RZ; Badwan SA; Halalmeh AI; Al-Khawaldeh MH; Atmeh MT; Jabali EH; Attieh O; Al-Soudi HS; Alkhatib LA; Alrawashdeh MT; Abdelqader AF; Ashokaibi OY; Shahin AA; Maaita FM
    Cureus; 2023 Jan; 15(1):e33736. PubMed ID: 36788889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KRAS mutations in patients with colorectal cancer in Libya.
    Abudabous A; Drah M; Aldehmani M; Parker I; Alqawi O
    Mol Clin Oncol; 2021 Oct; 15(4):197. PubMed ID: 34462653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific mutations in KRAS codon 12 are associated with worse overall survival in patients with advanced and recurrent colorectal cancer.
    Jones RP; Sutton PA; Evans JP; Clifford R; McAvoy A; Lewis J; Rousseau A; Mountford R; McWhirter D; Malik HZ
    Br J Cancer; 2017 Mar; 116(7):923-929. PubMed ID: 28208157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of KRAS mutation on outcome of patients with metastatic colorectal cancer.
    Chang YY; Lin JK; Lin TC; Chen WS; Jeng KJ; Yang SH; Wang HS; Lan YT; Lin CC; Liang WY; Chang SC
    Hepatogastroenterology; 2014 Oct; 61(135):1946-53. PubMed ID: 25713893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.